Atossa Therapeutics, Inc. Common Stock (ATOS) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
ATOS has 2 Form 4 insider filings recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001488039 (2026-04-11) ↗